Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios.
Autori:
Zielonke N, Geuzinge A, Heijnsdijk EAM, Heinävaara S, Senore C, Jarm K, de Koning HJ, van Ravesteyn NT, On Behalf Of The Eu-Topia Consortium.
Rivista:
Cancers (Basel) 2021; 13: 3360. doi: 10.3390/cancers13133360. PMID: 34283068 (IF 6.639)